Financials Aflac Incorporated

Equities

AFL

US0010551028

Life & Health Insurance

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
89.87 USD +2.15% Intraday chart for Aflac Incorporated +2.49% +8.93%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 38,830 31,238 38,627 44,731 48,211 51,066 - -
Enterprise Value (EV) 1 38,830 31,238 38,627 44,731 52,772 56,241 56,345 56,451
P/E ratio 11.9 x 6.67 x 9.14 x 10.9 x 10.6 x 11.2 x 13.3 x 12.7 x
Yield 2.04% 2.52% 2.26% 2.22% 2.04% 2.23% 2.27% 2.47%
Capitalization / Revenue 1.74 x 1.41 x 1.75 x 2.29 x 2.58 x 2.91 x 2.86 x 2.81 x
EV / Revenue 1.74 x 1.41 x 1.75 x 2.29 x 2.82 x 3.2 x 3.16 x 3.1 x
EV / EBITDA - - - - 10.3 x 9.69 x 9.58 x -
EV / FCF - - - - - 18.7 x 18.8 x -
FCF Yield - - - - - 5.33% 5.32% -
Price to Book 1.33 x 0.92 x 1.15 x 1.98 x 2.17 x 2.17 x 2.08 x 2 x
Nbr of stocks (in thousands) 734,018 702,445 661,528 621,789 584,380 568,222 - -
Reference price 2 52.90 44.47 58.39 71.94 82.50 89.87 89.87 89.87
Announcement Date 2/4/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 22,307 22,147 22,106 19,502 18,701 17,560 17,827 18,181
EBITDA 1 - - - - 5,126 5,805 5,882 -
EBIT 1 4,445 4,159 5,322 4,157 4,310 4,824 4,812 -
Operating Margin 19.93% 18.78% 24.07% 21.32% 23.05% 27.47% 27% -
Earnings before Tax (EBT) 1 4,445 4,159 5,322 4,604 5,262 5,581 4,832 4,566
Net income 1 3,304 4,778 4,325 4,201 4,659 4,550 3,613 3,623
Net margin 14.81% 21.57% 19.56% 21.54% 24.91% 25.91% 20.27% 19.93%
EPS 2 4.430 6.670 6.390 6.590 7.780 8.035 6.733 7.080
Free Cash Flow 1 - - - - - 3,000 3,000 -
FCF margin - - - - - 17.08% 16.83% -
FCF Conversion (EBITDA) - - - - - 51.68% 51% -
FCF Conversion (Net income) - - - - - 65.93% 83.03% -
Dividend per Share 2 1.080 1.120 1.320 1.600 1.680 2.006 2.042 2.217
Announcement Date 2/4/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 5,433 5,272 5,400 4,820 4,010 4,800 5,172 4,950 3,777 5,436 4,357 4,359 4,371 4,442 4,443
EBITDA 1 - - - - - - - 1,499 947 1,378 1,439 1,436 1,413 1,440 1,469
EBIT 1 1,233 1,143 1,134 880 1,001 1,133 1,139 1,298 739 1,163 1,200 1,214 1,158 1,229 1,258
Operating Margin 22.69% 21.68% 21% 18.26% 24.96% 23.6% 22.02% 26.22% 19.57% 21.39% 27.54% 27.86% 26.51% 27.67% 28.31%
Earnings before Tax (EBT) 1 1,233 1,276 1,701 1,103 524 1,342 1,825 1,805 289 2,170 1,439 1,436 1,413 1,298 1,308
Net income 1 1,039 1,032 1,388 1,596 185 1,188 1,634 1,569 268 1,879 893 895.3 847.7 905 892.4
Net margin 19.12% 19.58% 25.7% 33.11% 4.61% 24.75% 31.59% 31.7% 7.1% 34.57% 20.49% 20.54% 19.4% 20.38% 20.08%
EPS 2 1.570 1.580 2.160 2.530 0.3000 1.940 2.710 2.640 0.4600 3.250 1.569 1.602 1.534 1.654 1.650
Dividend per Share 2 0.3300 0.4000 0.4000 0.4000 0.4000 0.4200 0.4200 0.4200 0.4200 0.5000 0.4850 0.4850 0.4925 0.5275 0.5275
Announcement Date 2/2/22 4/27/22 8/1/22 10/31/22 2/1/23 4/26/23 8/1/23 11/1/23 1/31/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 4,561 5,175 5,279 5,385
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - 0.8898 x 0.8914 x 0.8975 x -
Free Cash Flow 1 - - - - - 3,000 3,000 -
ROE (net income / shareholders' equity) 12.6% 15.3% 12.9% 12.9% 13.8% 16.1% 14.8% 14.5%
ROA (Net income/ Total Assets) - 3.01% 2.49% 2.35% 3.61% 3.07% 3.04% -
Assets 1 - 158,927 173,596 178,424 129,230 148,401 119,049 -
Book Value Per Share 2 39.80 48.50 51.00 36.40 38.00 41.40 43.30 45.00
Cash Flow per Share - 8.320 7.460 6.080 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 2/4/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
89.87 USD
Average target price
85.25 USD
Spread / Average Target
-5.14%
Consensus
  1. Stock Market
  2. Equities
  3. AFL Stock
  4. Financials Aflac Incorporated